Double-Rotary Press is Designed for High-Volume Tablet Production
A new Korsch press offers flexibility to produce single and bilayer tablets.
A XT 600 double-rotary press from Korsch is geared toward high-volume production of single and bilayer tablets. An exchangeable turret offers the flexibility to efficiently produce a tablet of virtually any size and shape.
The tablet press offers a 60 kN or 100 kN compression column for precompression and main compression. The press has low noise and a patented carrier plate design that isolates vibration in the compression zone. The space-efficient design has a small footprint but ample access for cleaning, changeover, and turret exchange. Accessible, multifunction channels on the corners of the machine are non-load bearing and provide a place for cables, lubrication lines, and dust extraction ports to create an ergonomic and clean compression zone that permits streamlined changeover and turret exchange.
A new human-machine interface (HMI), the Smart-Touch HMI, has a 19-inch display that provides an intuitive operating experience, allowing operators to move, zoom, and scroll through content easily. The control capability is supplemented by multi-media online help that features pictures, videos, drawings, and access to machine manuals to support machine operation, maintenance, and troubleshooting.
Source: Korsch
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
